High levels of IgM against methylglyoxal-modified apolipoprotein B 100 is associated with less coronary artery calcification in patients with type 2 diabetes.

DSpace Repository

High levels of IgM against methylglyoxal-modified apolipoprotein B 100 is associated with less coronary artery calcification in patients with type 2 diabetes.

Details

Files for download

Find Full text There are no files associated with this item.

Overview of item record
Publication Article, peer reviewed scientific
Title High levels of IgM against methylglyoxal-modified apolipoprotein B 100 is associated with less coronary artery calcification in patients with type 2 diabetes.
Author Engelbertsen, Daniel ; Anand, DV ; Nordin Fredrikson, Gunilla ; Hopkins, D ; Corder, R ; Shah, Prediman K ; Lahiri, A ; Nilsson, Jan ; Bengtsson, Eva
Date 2011
DOI http://dx.doi.org/10.1111/j.1365-2796.2011.02411.x (link to publisher's fulltext.)
Link http://www.ncbi.nlm.nih.gov/pubmed/21668821 (external link to publication)
Host/Issue J Intern Med;
Volume In press
Language eng (iso)
Subject Medicine
Research Subject Categories::MEDICINE
Handle http://hdl.handle.net/2043/12826 Permalink to this page
Facebook

This item appears in the following Collection(s)

Details

Search


Browse

My Account

Statistics